Results 241 to 250 of about 10,060,126 (337)
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source
Utility in prognostication of continuous EEG monitoring in postanoxic coma: importance on timing in relation to the cardiac arrest. [PDF]
Piagnerelli M +3 more
europepmc +1 more source
Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu +18 more
wiley +1 more source
Identification of important outcomes for surgical and brace treatment of adolescent idiopathic scoliosis : qualitative analysis of the perspectives of young people, parents, and healthcare professionals. [PDF]
Graham-Wisener L +7 more
europepmc +1 more source
A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak +8 more
wiley +1 more source
Heart rate and clinical outcome after endovascular treatment in patients with anterior versus posterior circulation large vessel occlusion. [PDF]
Zhang L, Wang YJ, Chen HS.
europepmc +1 more source

